1. Identification of Prognostic Gene Biomarkers in Non-Small Cell Lung Cancer Progression by Integrated Bioinformatics Analysis
   Panagiotis Giannos et al, 2021, Biology CrossRef
2. The Prognostic Value of Multiple Systemic Inflammatory Biomarkers in Preoperative Patients With Non-small Cell Lung Cancer
   Kai Wang et al, 2022, Frontiers in Surgery CrossRef
3. Evaluation of cytokines in the tumor microenvironment of lung cancer using bronchoalveolar lavage fluid analysis
   Pascal Bezel et al, 2021, Cancer Immunology, Immunotherapy CrossRef
4. miR-29a-3p directly targets Smad nuclear interacting protein 1 and inhibits the migration and proliferation of cervical cancer HeLa cells
   Ying Chen et al, 2020, PeerJ CrossRef
5. Basophils as a potential therapeutic target in cancer
   Jicheng Zhang et al, 2021, Journal of Zhejiang University-SCIENCE B CrossRef
6. Yin Yang 1 impacts upon preeclampsia by regulating T reg /T H 17 cells and PI3K/AKT pathway
   Haowen Li et al, 2023, Journal of Immunotoxicology CrossRef
7. Advances in the role of microRNAs associated with the PI3K/AKT signaling pathway in lung cancer
   Yanting Wang et al, 2023, Frontiers in Oncology CrossRef
8. The Two Sides of YY1 in Cancer: A Friend and a Foe
   Sailu Sarvagalla et al, 2019, Frontiers in Oncology CrossRef
9. Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers
   Alicia Cristina Peña-Romero et al, 2022, Cancers CrossRef
10. Roles of IL-4, IL-13, and Their Receptors in Lung Cancer
    Yao Zhang et al, 2024, Journal of Interferon & Cytokine Research CrossRef
11. A BMPR2/YY1 Signaling Axis Is Required for Human Cytomegalovirus Latency in Undifferentiated Myeloid Cells
    Emma Poole et al, 2021, mBio CrossRef